Financials
- Market Capitalization 387.03 M
- Employee 120
- Founded 1995
- CEO N/A
- Website www.enanta.com
- Headquarter Massachusetts, United States
- FIGI BBG001V9NSB4
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3139 | IPSC Century Therapeutics, Inc. - Common Stock | 2.12 USD | -0.47% | -12.76% | -8.23% | +265.52% | 382.35 M USD | ||
| 3145 | AVIR Atea Pharmaceuticals, Inc. - common stock | 4.82 USD | +2.55% | -0.62% | +9.55% | +50.16% | 385.73 M USD | ||
| 3148 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 3.84 USD | -4.48% | -1.79% | -6.34% | +29.29% | 362.19 M USD | ||
| 3179 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.69 USD | +1.52% | -7.31% | -0.64% | +12.74% | 368.27 M USD |
Frequently asked questions about Enanta Pharmaceuticals, Inc. - Common Stock
What is the Enanta Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Enanta Pharmaceuticals, Inc. - Common Stock (ENTA) is 13.31. Over the past 24 hours, the stock has changed by +1.53%. Follow the ENTA chart for real-time price dynamics.
What is the stock ticker of Enanta Pharmaceuticals, Inc. - Common Stock?
Enanta Pharmaceuticals, Inc. - Common Stock trades under the ticker ENTA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Enanta Pharmaceuticals, Inc. - Common Stock stock going up?
ENTA has changed by -9.15% over the last week, +16.35% over the last month, and +101.97% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Enanta Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Enanta Pharmaceuticals, Inc. - Common Stock reported net income of -13.09 M for the last quarter. The previous quarter showed -11.94 M, which means net income changed by -9.66%.
How many employees does Enanta Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Enanta Pharmaceuticals, Inc. - Common Stock has 120 employees. Workforce size can provide additional context about the company's scale and operations.
What is Enanta Pharmaceuticals, Inc. - Common Stock EBITDA?
Enanta Pharmaceuticals, Inc. - Common Stock EBITDA is -11.55 M, and its EBITDA margin is -67.31%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Enanta Pharmaceuticals, Inc. - Common Stock stock?
You can buy Enanta Pharmaceuticals, Inc. - Common Stock (ENTA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Enanta Pharmaceuticals, Inc. - Common Stock stock?
Investing in Enanta Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENTA chart and related analysis on metatrader.com as part of your research.